These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Chanson P; Dib A; Visot A; Derome PJ Eur J Endocrinol; 1994 Sep; 131(3):229-34. PubMed ID: 7921205 [TBL] [Abstract][Full Text] [Related]
4. [Acromegaly associated with McCune-Albright syndrome]. Tóth M; Töke J; Kiss E; Bernád I; Miheller P; Szücs N; Rácz K Orv Hetil; 2002 May; 143(19 Suppl):1070-3. PubMed ID: 12063863 [TBL] [Abstract][Full Text] [Related]
5. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis. Kovacs K; Horvath E; Thorner MO; Rogol AD Virchows Arch A Pathol Anat Histopathol; 1984; 403(1):77-86. PubMed ID: 6426154 [TBL] [Abstract][Full Text] [Related]
6. Acromegaly and its treatment in the McCune-Albright syndrome. Premawardhana LD; Vora JP; Mills R; Scanlon MF Clin Endocrinol (Oxf); 1992 Jun; 36(6):605-8. PubMed ID: 1424186 [TBL] [Abstract][Full Text] [Related]
7. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385 [TBL] [Abstract][Full Text] [Related]
8. A case of McCune-Albright syndrome associated with Gs alpha mutation in the bone tissue. Sargin H; Gozu H; Bircan R; Sargin M; Avsar M; Ekinci G; Yayla A; Gulec I; Bozbuga M; Cirakoglu B; Tanakol R Endocr J; 2006 Feb; 53(1):35-44. PubMed ID: 16543670 [TBL] [Abstract][Full Text] [Related]
9. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction. Chung KF; Alaghband-Zadeh J; Guz A Am J Dis Child; 1983 Feb; 137(2):134-6. PubMed ID: 6401383 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein. Gessl A; Freissmuth M; Czech T; Matula C; Hainfellner JA; Buchfelder M; Vierhapper H J Clin Endocrinol Metab; 1994 Oct; 79(4):1128-34. PubMed ID: 7962285 [TBL] [Abstract][Full Text] [Related]
11. [A case of fibrous dysplasia (McCune Albright syndrome) associated with acromegaly]. Chiba Y; Tani N; Tamura N; Nakamura H; Igarashi K; Momotsu T; Tsuda A; Ito S; Shibata A; Tamura T Nihon Naibunpi Gakkai Zasshi; 1991 Mar; 67(3):239-48. PubMed ID: 2070893 [TBL] [Abstract][Full Text] [Related]
12. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. Sherman SI; Ladenson PW J Endocrinol Invest; 1992 Mar; 15(3):185-90. PubMed ID: 1624678 [TBL] [Abstract][Full Text] [Related]
13. Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma. Zumkeller W; Jassoy A; Lebek S; Nagel M J Pediatr Endocrinol Metab; 2001 May; 14(5):553-9. PubMed ID: 11393578 [TBL] [Abstract][Full Text] [Related]
19. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide. Garcia MB; Koppeschaar HP; Lips CJ; Thijssen JH; Krenning EP J Endocrinol Invest; 1994 Jan; 17(1):59-65. PubMed ID: 7911814 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome. Yao Y; Liu Y; Wang L; Deng K; Yang H; Lu L; Feng F; Xing B; You H; Jin Z; Wang R; Pan H; Chen S; Zhu H Eur J Endocrinol; 2017 Mar; 176(3):295-303. PubMed ID: 28007843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]